Page 26 - Albert Bourla News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The drugmaker invested in cancer drugs last year amid declining Covid vaccine sales.

Pfizer slashes 2022 earnings outlook despite strong first quarter Covid vaccine and antiviral sales : Rashtra News #Pfizer #slashes #earnings #outlook #strong #quarter #Covid #vaccine #antiviral #sales Albert Bourla, chief executive officer of Pfizer pharmaceutical company, arrives to ring the closing bell at the New York Stock Exchange.Drew Angerer | Getty ImagesPfizer on Tuesday slashed

Pfizer on Thursday said a single dose of its new respiratory syncytial virus (RSV) vaccine Abrysvo maintained its ability to protect against the illness through a second year of respiratory disease season. The company said in a press release that the vaccine's efficacy against RSV-associated lower respiratory tract disease with three or more symptoms was 77.8% through season two, compared with efficacy of 88.9% after the first RSV season, which led to the shot's U.S. approval. Cumulative efficacy over both seasons after around 16.4 months of disease surveillance was 81.5%, Pfizer s...

A group of Republican lawmakers in the U.S. are demanding answers from Pfizer over a financial contribution in Canada — an allegedly minor one. It went to a group promoting medically-assisted death.

(JTA) — Five Israeli groups supporting Israelis held hostage in Gaza and their families will receive the 2024 Genesis Prize, the $1 million award known as the “Jewish Nobel.”